The Pharma Flash - Biopharm CDMO adds Cell and Gene Therapy Services, FDA Approvals and more | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Tuesday, June 27, 2023

Biopharm CDMO adds Cell and Gene Therapy Services, FDA Approvals and more

1. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

2. FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes

3. Veeva Business Consulting Expands with New R&D Services

4. FDA Issues Draft Guidance About Formal Dispute for OTC Monograph Drugs

5. Andelyn Biosciences Opens New 180,000 Square Foot Manufacturing HQ

2025 Contract Services Directory and Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary print or
digital subscription

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.